BioSpace News Archive

Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles

Days after Sanofi reported back-to-back failures for its BTK inhibitor, Roche’s fenebrutinib on Wednesday scored a mid-stage win in relapsing multiple sclerosis, demonstrating near-total elimination of disease activity.

September 4, 2024

·

2 min read

·

Tristan Manalac

Pictured: Nasdaq headquarters in New York/iStock,

IPO

Lilly Partner BioAge Files for IPO to Advance Obesity Candidate

BioAge will use the proceeds from the initial public offering to move its oral apelin receptor agonist azelaprag past its Phase III STRIDES study and into a registrational Phase III trial.

September 4, 2024

·

2 min read

·

Tristan Manalac

Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.

Layoffs

ImmunityBio to Lay Off 16, Will Likely Need Additional Capital

ImmunityBio will lay off 16 employees in California and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.

September 4, 2024

·

2 min read

·

Angela Gabriel

Business

ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron

Proceeds from the oversubscribed financing will be used to advance ArsenalBio’s lead programs, which include a handful of solid tumor cell therapy candidates.

September 4, 2024

·

1 min read

·

Annalee Armstrong

Press Releases

Dovetail Genomics Showcases New VariLink™ Assay Findings at AGBT Conference

September 4, 2024

·

3 min read

Press Releases

Curis to Present at Upcoming Healthcare Conferences in September